Add The Wire As Your Trusted Source
For the best experience, open
https://m.thewire.in
on your mobile browser.
AdvertisementAdvertisement

Study Finds Pakistan Typhoid Outbreak Caused by Drug-Resistant ‘Superbug’ Strain

Researchers who analysed the genetics of the typhoid strain found it had mutated and acquired an extra piece of DNA to become resistant to multiple antibiotics.
Researchers who analysed the genetics of the typhoid strain found it had mutated and acquired an extra piece of DNA to become resistant to multiple antibiotics.
study finds pakistan typhoid outbreak caused by drug resistant ‘superbug’ strain
Lab technicians testing for the presence of bacteria. Credit: Reuters
Advertisement

Researchers who analysed the genetics of the typhoid strain found it had mutated and acquired an extra piece of DNA to become resistant to multiple antibiotics.

Lab technicians testing for the presence of bacteria. Credit: Reuters

London: An outbreak of typhoid fever in Pakistan is being caused by an extensively drug resistant "superbug" strain, a sign that treatment options for the bacterial disease are running out, scientists said on Tuesday.

Researchers from Britain's Wellcome Sanger Institute who analysed the genetics of the typhoid strain found it had mutated and acquired an extra piece of DNA to become resistant to multiple antibiotics.

An outbreak of drug-resistant typhoid that began in Hyderabad in Pakistan in November 2016 is still spreading, according to experts from Aga Khan University who worked with the Sanger team.

Official data on case numbers and deaths are not available, but local Pakistan media reports say health authorities detected more than 800 cases of drug-resistant typhoid in Hyderabad alone in a 10-month period between 2016 and 2017.

Advertisement

The researcher found the bacterial strain causing the outbreak is now resistant to five antibiotics in total, more than seen in any outbreak before.

"This is the first time we have seen an outbreak of extensively drug-resistant typhoid," said Elizabeth Klemm, who co-led the analysis work at the Sanger Institute. "This outbreak was caused by a multidrug-resistant strain that had gone a step further and acquired an extra piece of DNA encoding additional genes for antibiotic resistance."

Advertisement

Typhoid is a highly contagious infection caused by the Salmonella enterica serovar Typhi bacteria. It is contracted by consuming contaminated foods or drinks and symptoms include nausea, fever, abdominal pain and pink spots on the chest. Untreated, it can be fatal.

Scientists at Aga Khan University in Pakistan anxious to find ways to tackle an ongoing outbreak there contacted the Sanger in the spring of 2017 and asked scientists there to genetically analyse samples.

Advertisement

The team found it was being caused by a strain known as H58, which is already known to be linked to drug-resistant cases. Looking further, they found this H58 strain had gained an extra strand of bacterial DNA – a plasmid – that encoded for additional antibiotic resistance genes. Thestudy's results were published in the scientific journal mBio.

Advertisement

Charlie Weller, head of vaccines at Britain's Wellcome Trust global health charity, said the findings were a clear warning that "treatment options for typhoid are running out" and focussing on prevention was now vital.

A new vaccine against typhoid was approved last month by the World Health Organisation and the GAVI global vaccine alliance said last year it had earmarked $85 million to help support the introduction of typhoid vaccines in poor countries.

Previous research by Sanger scientists published in 2015 found that the H58 strain of typhoid first emerged in South Asia 25 to 30 years ago. It initially took hold in Asia and Africa before spreading around the world, becoming the dominant strain by 2015.

(Reuters)

This article went live on February twenty-first, two thousand eighteen, at thirteen minutes past five in the evening.

The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.

Advertisement
Advertisement
tlbr_img1 Series tlbr_img2 Columns tlbr_img3 Multimedia